Sign in

CIK 0001455365

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

COGNITION THERAPEUTICS INC

Sign in to watch
Ticker
CGTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 412-481-2210
Business address
2500 WESTCHESTER AVE, PURCHASE, NY, 10577
Former names
COGNITION THERAPUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-17 Fletcher Aaron G.L. Director Grant or award +25,000 81,229
2026-06-17 Khattar Jack A. Director Grant or award +25,000 73,500
2026-06-17 Monia Brett P Director Grant or award +25,000 73,500
2026-06-17 Wallace Peggy Director Grant or award +25,000 111,461
2026-06-17 RICHSTONE ELLEN B Director Grant or award +25,000 83,500
2026-05-01 Doyle John Brendan Chief Financial Officer Shares withheld for taxes −8,567 $1.28 $11K 618,942
2026-04-16 Doyle John Brendan Chief Financial Officer Purchase +10,000 $1.13 $11K 627,509
2026-04-16 Ricciardi Lisa CEO & President Purchase +9,175 $1.10 $10K 1,715,851
2026-04-16 Caggiano Anthony Chief Medical Officer Purchase +10,000 $1.11 $11K 874,906
2026-02-15 Ricciardi Lisa CEO & President Shares withheld for taxes −5,850 $1.12 $7K 1,706,676
2026-02-15 Doyle John Brendan Chief Financial Officer Shares withheld for taxes −1,560 $1.12 $2K 617,509
2026-02-15 Caggiano Anthony Chief Medical Officer Shares withheld for taxes −4,680 $1.12 $5K 864,906
2026-02-04 Ricciardi Lisa CEO & President Shares withheld for taxes −51,704 $1.03 $53K 1,712,526
2026-02-04 Doyle John Brendan Chief Financial Officer Shares withheld for taxes −26,921 $1.03 $28K 619,069
2026-02-04 Caggiano Anthony Chief Medical Officer Shares withheld for taxes −26,919 $1.03 $28K 869,586
2026-02-03 Ricciardi Lisa CEO & President Grant or award +800,000 1,790,266
2026-02-03 Ricciardi Lisa CEO & President Shares withheld for taxes −26,036 $1.12 $29K 1,764,230
2026-02-03 Doyle John Brendan Chief Financial Officer Grant or award +200,000 645,990
2026-02-03 Caggiano Anthony Chief Medical Officer Grant or award +400,000 907,993
2026-02-03 Caggiano Anthony Chief Medical Officer Shares withheld for taxes −11,488 $1.12 $13K 896,505

Page 1 of 13 · 247 trades